Molecular rationale for the pharmacological treatment of Alzheimer's disease.
about
Evidence for natural antisense transcript-mediated inhibition of microRNA functionTaspine: bioactivity-guided isolation and molecular ligand-target insight of a potent acetylcholinesterase inhibitor from Magnolia x soulangianaDysregulated mitochondrial genes and networks with drug targets in postmortem brain of patients with posttraumatic stress disorder (PTSD) revealed by human mitochondria-focused cDNA microarrays.Anti-inflammatory and immune therapy for Alzheimer's disease: current status and future directions.Neuronal AChE splice variants and their non-hydrolytic functions: redefining a target of AChE inhibitors?Multiple e-Pharmacophore Modeling Combined with High-Throughput Virtual Screening and Docking to Identify Potential Inhibitors of β-Secretase(BACE1).Changes of rat plasma total low molecular weight antioxidant level after tabun exposure and consequent treatment by acetylcholinesterase reactivators.RAGE mediates Aβ accumulation in a mouse model of Alzheimer's disease via modulation of β- and γ-secretase activity.Dementia in life writing: our health care system in the words of the sufferer.Literature and science: a different look inside neurodegeneration.
P2860
Q21184035-6B92BB03-126B-4641-BA29-CF82145D333CQ24598138-66E76667-C393-458E-87BB-70876AAA28C0Q36817945-B12E53C2-8B98-4AB7-ABC0-5656DD4BE669Q37101754-B4AA2A9B-8616-4D00-99E2-BA81A7FBAC44Q38132755-CCB0B66E-4525-426E-8D1D-ABFF69833B2FQ39535413-4FF8E0D6-E51A-453B-8F7D-D9F494180D64Q47427303-9EF3F42C-1DC2-40AD-B34C-76740533DC72Q47867340-4D1BA482-39DB-4EC9-99F3-DD3F5997F1A3Q48450927-8B7353A7-A85C-42F7-BC9D-20747A77F542Q48474389-9DA3DD29-750C-4ECC-B8C6-9CFB4D9404BB
P2860
Molecular rationale for the pharmacological treatment of Alzheimer's disease.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Molecular rationale for the pharmacological treatment of Alzheimer's disease.
@ast
Molecular rationale for the pharmacological treatment of Alzheimer's disease.
@en
type
label
Molecular rationale for the pharmacological treatment of Alzheimer's disease.
@ast
Molecular rationale for the pharmacological treatment of Alzheimer's disease.
@en
prefLabel
Molecular rationale for the pharmacological treatment of Alzheimer's disease.
@ast
Molecular rationale for the pharmacological treatment of Alzheimer's disease.
@en
P1433
P1476
Molecular rationale for the pharmacological treatment of Alzheimer's disease
@en
P2093
Fabrizio Gardoni
Monica Di Luca
P356
10.2165/00002512-200522001-00003
P478
22 Suppl 1
P577
2005-01-01T00:00:00Z
P6179
1037778200